Regular article
Identification of redundant angiogenic sites in laminin α1 and γ1 chains

https://doi.org/10.1016/S0014-4827(03)00056-9Get rights and content

Abstract

The degradation of the extracellular matrix is one of the first steps involved in angiogenesis, the formation of new vessels from preexisting ones. Laminin, a large extracellular matrix protein, has many biological activities, including the promotion of angiogenesis. Screening of the laminin-1 chains identified 20 angiogenic peptides, of which, A13 and C16, from the α1 and γ1 chains, respectively, were the most active. We recently identified the receptors for C16 as the integrins α5β1 and αvβ3. Here, we show unexpectedly that A13 is a redundant active site to C16 present in the N-terminal globular domain of the α1 chain. The peptides are located in homologous sites present in the last globular domains of their respective chains, and their amino acids are 66% conserved, as compared to the inactive homologous site in the β1 chain, B19 to B20, which is only 18%–23% conserved. Cell attachment studies demonstrated that both A13 and C16 reciprocally inhibited their adhesion activity, whereas the corresponding laminin β1 chain peptides were inactive. Chorioallantoic membrane assays showed that the in vivo angiogenic activity of A13 is blocked by a C16 antagonist, C16S, which also binds to the same integrin receptors. A13 affinity chromatography and immunoprecipitation analysis showed that the αvβ3 and α5β1 integrin receptors bind to this sequence. We have therefore identified redundant activity on two laminin chains. These highly conserved functional sites are likely important mediators of the biological responses of laminins because either one or both of these chains (active sites) are present in almost all laminin isoforms identified to date.

Introduction

The first step in angiogenesis involves breakdown of the basement membrane matrix that allows endothelial cells to migrate, sprout, and form new vessels. The basement membrane contains many bioactive molecules that affect endothelial cell behavior when released during its degradation, including growth factors (i.e., FGFs, PDGF, TGFβ) and extracellular matrix components, such as laminin, a major basement membrane protein [1], [2], [3]. Thus, it is conceivable that as a result of basement membrane degradation, additional angiogenic stimuli are released and become available to sustain new vessel formation [4].

A variety of angiogenic stimulators and inhibitors have been identified which are small bioactive molecules contained within larger molecules. These small molecules are generated during proteolysis or protein processing and include thymosin α1, collagen IV fragments (NCI domains), vasculostatin, endostatin, and angiostatin [5], [6], [7], [8], [9], [10]. Laminin is highly protease sensitive, and it is likely that many small fragments are generated during the breakdown of the basement membrane matrix [11]. Laminin is a high molecular weight (Mr = 900,000) glycoprotein composed of three chains: α, β, and γ. Five different α, three β, and three γ chains, which assemble into at least 12 different laminin isoforms, have been identified to date [12], [13], [14]. We recently screened laminin-1 (α1β1γ1) for angiogenic activity using 12-mer overlapping synthetic peptides to all three chains. Twenty angiogenic peptides were identified which promoted endothelial cell adhesion, migration, and sprouting from aortic rings [15], [16]. The most highly active peptides were identified and included peptide A13 (residues 121 to 133 on the α1 chain), B160 (residues 1607 to 1618 on the β1 chain), and C16 (residues 139 to 149 on the γ1 chain). C16 was very angiogenic in vivo and bound to integrins α5β1 and αvβ3 [17]. Its effect was not inhibited by an RGD peptide and did not involve MAP kinase [17]. Here, we have investigated the most active peptide on the α1 chain, A13. Our data show that A13 is a homologous site on the α1 chain to C16 on the γ1 chain, has considerable sequence homology to C16, competes for adhesion to itself, as expected, and to C16, and utilizes the same cell surface receptors. The homologous site on the β1 chain was not active and demonstrated less sequence homology. These unexpected findings of redundant active sites on laminin indicate a conservation of activity and suggest the importance of this domain as a functional site on laminin-1.

Section snippets

Materials and methods

All peptides were synthesized by the CBER’s Facility for Biotechnology Resources, FDA, Bethesda, MD. Peptides contained an N-terminal amide and included A13 (RQVFQVAYIIIKA), B19 (LEAEFHFTHLIM), B20 (HLIMTFKTFRPA), B19-20 (LEAEFHFTHLIMTFKTFRPA), C16 (KAFDITYVRLKF) (Fig. 1), C16S (DFKLFAVTIKYR), and C16R (FKLRVYTIDFAK). C16S and C16R are scrambled peptides of C16. Laminin-1 was prepared from the EHS tumor as described [18]. Integrin antibodies were obtained from Chemicon.

The homologous β1 chain peptide does not share activity with A13 and C16

We have previously observed that peptides A13 and C16 promote endothelial cell attachment and inhibit adhesion to laminin-1 [15], [16]. Because both sequences reside on homologous areas of the globular N-terminal domains of the α1 and γ1 chains, respectively, we determined whether this activity was also present in the homologous region of the β1 chain corresponding to peptide B19 (Fig. 1). Initial screening of overlapping peptides covering sequences in this domain did not show binding activity

Discussion

The basement membrane of the endothelium contains many extracellular matrix proteins, including collagen, proteoglycans, glycosaminoglycans, and laminins. During the initial step of angiogenesis, the extracellular matrix becomes degraded, releasing bound growth factors, such as bFGF, that can themselves stimulate angiogenesis. In addition, small fragments that are generated during the degradation of the matrix can contain biologically active sites that can influence angiogenesis. Among these

References (36)

  • J.F. Talts et al.

    Structural and chemical analysis of the recombinant G domain of the laminin alpha4 chain and its proteolytic processing in tissues

    J. Biol. Chem.

    (2000)
  • S.P. Lee et al.

    Sickle cell adhesion to lamininpotential role for the alpha 5 chain

    Blood

    (1998)
  • Y. Maeshima et al.

    Extracellular matrix derived peptide binds to alpha v beta 3 integrin and inhibits angiogenesis

    J. Biol. Chem.

    (2001)
  • I.F. Dunn et al.

    Growth factors in glioma angiogenesisFGFs, PDGF, EGF, and TGFs

    J. Neurooncol.

    (2000)
  • M. Klagsbrun

    Mediators of angiogenesisthe biological significance of basic fibroblast growth factor (bFGF)-heparin and heparan sulfate interactions

    Semin. Cancer Biol.

    (1992)
  • I. Vlodavsky et al.

    Extracellular matrix-resident basic fibroblast growth factorimplication for the control of angiogenesis

    J. Cell Biochem.

    (1991)
  • K.M. Malinda et al.

    Thymosin alpha 1 stimulates endothelial cell migration, angiogenesis, and wound healing

    J. Immunol.

    (1998)
  • P.C. Colorado et al.

    Anti-angiogenic cues from vascular basement membrane collagen

    Cancer Res.

    (2000)
  • Cited by (38)

    • Re-epithelialization of adult skin wounds: Cellular mechanisms and therapeutic strategies

      2019, Advanced Drug Delivery Reviews
      Citation Excerpt :

      Five α-, three β-, and three γ-laminin chains assemble to form more than 16 different αβγ laminin trimers. Peptides from the N-terminal domains of the α1 and γ1 laminin chains, originally identified for their angiogenic properties, have been shown to have a stimulating effect on granulation tissue formation and re-epithelialization when tested on full-thickness wounds in rats [326,327]. A laminin-α1 C-terminus-derived peptide conjugated to a chitosan membrane has been proposed as scaffold material to deliver keratinocytes to a wound bed [328,329].

    • Natural biomaterials for regenerative medicine applications

      2014, Regenerative Medicine Applications in Organ Transplantation
    • Exploiting bacterial peptide display technology to engineer biomaterials for neural stem cell culture

      2011, Biomaterials
      Citation Excerpt :

      However, identifying new ligands that bind these and other receptors could aid in engineering biomaterials and production of cell-based therapies for the clinic, as well as in gaining a better understanding of signaling mechanisms that regulate cell function [23,25–28]. However, while various cell-binding domains—such as RGD and IKVAV motifs— [29,30] have been identified in many ECM proteins, many peptides mimicking those domains are not as active as the full ECM proteins, as evidenced by the fact that few of them support the culture of cells to the same extent of the native protein [12,29–36]. In addition, many of the important signaling domains in ECM proteins may not be known, and for example only recently has the αv integrin binding domain in fibronectin been identified [37].

    View all citing articles on Scopus
    View full text